TY  - BOOK
AU  - Burley, Denis M. (ed)
AU  - Clarke, Joan M. (ed)
AU  - Lasagna, Louis (ed)
TI  - Pharmaceutical medicine
SN  - 0340525177
PY  - 1993///
CY  - London
PB  - Edward Arnold
KW  - DRUG INDUSTRY
KW  - PHARMACY
N1  - How are medicines discovered?, Brian B Newbould. Preclinical toxicity testing, Roger W Brimblecombe / A D Dailan. Making drugs into medicines, John M Padfield. Clinical trials, Denis B Burley / Louis Lasagna. Statistical considerations, Win M Castle / Alan F Ebbutt. Adverse reactions, postmarketing surveillance and pharmacoepidemiology, Judith K. Jones / J.E. Idanpaan-Heikkila. The regulation of medicines in the UK, David B Jeffreys / Gerald Jones. The regulation of medicines in Europe, Don Maclean. The regulation of pharmaceutical products in the USA, Peter Barton Hutt. Issues in the economics of the pharmaceutical indistry, Klaus von Grebmer. Ehics of clinical research, Brian T Marsh. The pharmaceutical physician, Karen Summers. Introduction to the legal aspects of pharmaceutical medicine: a brief overview of some emerging issues, Diana Brahams. Appendix 1 Clinical trial compensation guidelines
N2  - Hardback; Pharmaceutical medicine is the area of common ground between medical practice, the pharmaceutical industry and government. It includes all the medical aspects of pharmaceutical companies' research work in the development of new drugs, but pharmaceutical physicians must also be aware of the political, economic and legal framework in which they practise.This book looks at these aspects of pharmaceutical medicine to keep up with the changes in this field but also to cover the regulation of pharmaceutical products in the USA. This book is designed to be of interest to pharmacologists, clinical research associates and pharmaceutical industry marketing personnel and management
ER  -